Current Report Filing (8-k)
16 February 2021 - 11:04PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report: February 16, 2021
ITEM 9 LABS CORP.
(Exact name of registrant as specified in its
charter)
Delaware
|
|
000-54730
|
|
96-0665018
|
(State of other jurisdiction
|
|
(Commission
|
|
(IRS Employer
|
of incorporation)
|
|
File Number)
|
|
Identification No.)
|
2727 N 3rd Street, Suite
201, Phoenix AZ 85004 (Address of principal executive offices and zip code)
1-833-867-6337
(Registrant’s telephone number, including
area code)
N/A
(Former name or former address, if changed since last
report)
Check the appropriate box below if the Form
8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions
(see General Instruction A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
CFR 240.14a -12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act (17 CFR 240.14d -2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act (17 CFR 240.13e -4(c))
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2
of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company. ☐
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Securities registered pursuant to Section 12(b)
of the Act:
Title of each class
|
|
Trading Symbol(s)
|
|
Name of each exchange on which registered
|
|
|
|
|
|
Item 7.01
|
Regulation FD Disclosure.
|
Attached
hereto as Exhibit 99.1 is a press release we issued on February 16, 2021, announcing Item 9 Labs Corp’s first quarter 2021
financial results.
Item 9.01
|
Financial Statements and Exhibits.
|
(d) Exhibits.
Exhibit No.
|
|
Description
|
|
|
|
99.1
|
|
Press
Release issued by Item 9 Labs Corp. on February 16, 2021, announcing Item 9 Labs Corp’s first quarter 2021 financial
results.
|
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.
|
ITEM 9 LABS CORP.
|
|
|
|
Dated: February 16, 2021
|
By:
|
/s/ Robert Mikkelsen
|
|
|
Robert Mikkelsen
|
|
|
Chief Financial Officer
|
Item 9 Labs (CE) (USOTC:INLB)
Historical Stock Chart
From Apr 2024 to May 2024
Item 9 Labs (CE) (USOTC:INLB)
Historical Stock Chart
From May 2023 to May 2024